About PainChek
PainChek is a company based in Sydney (Australia) founded in 2010. PainChek offers products and services including PainChek App and PainChek Analytics. PainChek operates in a competitive market with competitors including Remedee Labs, Sure Med Compliance, Neurolytic Healthcare, PainQx and Samdoc, among others.
- Headquarter Sydney, Australia
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
$2.19 M (USD)25.98as on Jun 30, 2025
-
Net Profit
-$5.01 M (USD)7.65as on Jun 30, 2025
-
EBITDA
-$5.94 M (USD)4.18as on Jun 30, 2025
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of PainChek
PainChek is a publicly listed company on the ASX with ticker symbol PCK in Australia, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of PainChek
PainChek offers a comprehensive portfolio of products and services, including PainChek App and PainChek Analytics.
Mobile app for AI-driven pain evaluations in care settings
Portal providing insights for optimizing pain management
People of PainChek
Unlock access to complete
Unlock access to complete
Funding Insights of PainChek
Investors in PainChek
PainChek has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Gwent Regional Partnership Board.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Health and wellbeing outcomes are improved for Gwent residents.
|
Locked | Locked | Locked |
Investor details for PainChek
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PainChek
Investment portfolio details for PainChek
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PainChek
Detailed financials for PainChek
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Painchek Comparisons
Peer comparison for PainChek
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PainChek
PainChek operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Remedee Labs, Sure Med Compliance, Neurolytic Healthcare, PainQx and Samdoc, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Endorphin stimulation therapy for pain management is developed.
|
|
| Locked | Locked | Locked |
Provider of a digital health platform for pain management
|
|
| Locked | Locked | Locked |
Smart medical devices for neurological disorder treatment are developed.
|
|
| Locked | Locked | Locked |
AI based pain measurement platform for human and veterinary care providers
|
|
| Locked | Locked | Locked |
Medical decision support tools for doctors are provided by Samdoc.
|
Detailed competitors of PainChek
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Painchek
Complete news archive for PainChek
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PainChek
PainChek was founded in 2010 and raised its 1st funding round 9 years after it was founded.
PainChek is headquartered in Sydney, Australia. It is registered at Sydney, New South Wales, Australia.
Philip Daffas is the current CEO of PainChek.
Annual revenue of PainChek is $2.19M as on Jun 30, 2025.
PainChek was established in 2010 in Sydney, Australia, within the healthcare technology sector. A mobile application is developed for pain assessment and monitoring through facial recognition. The tool assists caregivers and patients with cognitive impairments, such as dementia, in reporting pain accurately. Treatment compliance and effectiveness are tracked by caregivers via the apps features. Operations focus on enabling reliable pain management in clinical and home settings.
PainChek's top competitors include Remedee Labs, Sure Med Compliance and Neurolytic Healthcare.
PainChek offers PainChek App and PainChek Analytics.
Yes, PainChek is publicly traded on ASX under the ticker symbol PCK.
PainChek has 1 investor. Key investors include Gwent Regional Partnership Board.
The ticker symbol of PainChek is PCK on ASX.